The AIM-HI Beacon Award for Women Leaders in Oncology recognizes outstanding women leaders in all sectors of the health and life sciences industry who have made a significant impact on advancing cancer treatment, detection, and diagnosis for patients worldwide through the development and commercialization of novel technologies, advocacy, and/or implementation of public policy.
The 2024 Beacon Award is open for nominations until May 31, 2024. The 2024 Beacon Award recipient will be awarded an authentic gold medal and honored at a Luncheon Award Ceremony during the Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship at the National Press Club in Washington, DC on October 18, 2024. Learn more and submit an online nomination to honor your heroine today!
- Sujuan Ba, Ph.D., Co-Chair, CEO & Co-Founder, AIM-HI Accelerator Fund; President & CEO, National Foundation for Cancer Research
- Webster Cavenee, Ph.D., Co-Chair, Distinguished Professor Emeritus, University of California San Diego
- Anna D. Barker, Ph.D., Chief Strategy Officer, Ellison Institute for Transformative Medicine (2022 Winner)
- Deborah Dunsire, M.D., President & CEO, Lundbeck
- Bahija Jallal, Ph.D., CEO & Director of the Board, Immunocore
- Karen Knudsen, MBA, Ph.D., CEO, American Cancer Society
- Andrew Plump, M.D., Ph.D., President, Research & Development, Takeda Pharmaceutical
We encourage you to visit our Oncology Metaverse to view the recorded videos from the event and hear inspiring speeches and discussions from world-class researchers, clinicians, entrepreneurs, industry leaders, investors, advocates, and cancer patients and survivors.
Together, we can make the next generation of cancer treatments a reality.